Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. patient with kidney disease
Show results for

Companies

News

Refine by
Date

  • Older

Patient With Kidney Disease Articles & Analysis: Older

8 articles found

Glycated Collagen Protein Detection

Glycated Collagen Protein Detection

Glycated collagen mainly exists in various tissues in the human body, especially those rich in collagen, such as skin, bones, joints, blood vessels, and other connective tissues.Under normal physiological conditions, glycation occurs as a natural biochemical process, but its degree is usually low. In certain disease states, especially in patients with diabetes, ...

ByMtoZ Biolabs


Conceptual Considerations for Device-Based Therapy in Acute Decompensated Heart Failure

Conceptual Considerations for Device-Based Therapy in Acute Decompensated Heart Failure

Failure of Medical Therapy in ADHF: an Ode to the Kidneys The pathophysiology of fluid retention in ADHF in patients with advanced disease has been detailed previously (Figure 2A).21 In brief, reduced circulating blood pressure and cardiac output due to impaired contractility activates baroceptors, stimulates the renin-angiotensin-aldosterone ...

BySecond Heart Assist, Inc.


An Early Study on the Mechanisms that Allow Tissue-Engineered Vascular Grafts to Resist Intimal Hyperplasia

An Early Study on the Mechanisms that Allow Tissue-Engineered Vascular Grafts to Resist Intimal Hyperplasia

Abstract : Intimal hyperplasia is one of the prominent failure mechanisms for arteriovenous fistulas and arteriovenous access grafts. Human tissue-engineered vascular grafts (TEVGs) were implanted as arteriovenous grafts in a novel baboon model. Ultrasound was used to monitor flow rates and vascular diameters throughout the study. Intimal hyperplasia in the outflow vein of TEVGs was assessed at ...

ByHumacyte, Inc.


Five Year Outcomes in Patients with End Stage Renal Disease Who Received a Bioengineered Human Acellular Vessel for Dialysis Access

Five Year Outcomes in Patients with End Stage Renal Disease Who Received a Bioengineered Human Acellular Vessel for Dialysis Access

Objective: Patients with end stage renal failure who require haemodialysis suffer morbidity and mortality due to vascular access. Bioengineered human acellular vessels (HAVs) may provide a haemodialysis access option with fewer complications than other grafts. In a prospective phase II trial from 2012 to 2014 (NCT01744418), HAVs were implanted into 40 haemodialysis patients at three sites in ...

ByHumacyte, Inc.


Facing Treatment of Kidney Disease with Hearing Disabilities

Facing Treatment of Kidney Disease with Hearing Disabilities

Around 37 million people in the United States and around 700 million people worldwide have chronic kidney disease which require patients to utilize dialysis centers. These dialysis clinics provide lifesaving treatments to the patients that need them. While having any medical procedure performed, communication ...

BySafe’N’Clear, Inc.


3 Things That Google’s Healthcare Artificial Intelligence Desperately Needs

3 Things That Google’s Healthcare Artificial Intelligence Desperately Needs

As a result of all of this, the National Kidney Foundation and KDIGO (Kidney Disease Improving Global Outcome) unanimously agree that: “Serum creatinine alone is not the best way to detect kidney disease especially in the early stages”. ...

ByPotrero Medical


Costs Attributable to Arteriovenous Fistula and Arteriovenous Graft Placements in Hemodialysis Patients with Medicare coverage

Costs Attributable to Arteriovenous Fistula and Arteriovenous Graft Placements in Hemodialysis Patients with Medicare coverage

Keywords Vascular access · Hemodialysis · Healthcare costs · Health economics · Arteriovenous fistula · Arteriovenous graft Abstract Introduction: Hemodialysis (HD) in end-stage renal disease (ESRD) patients requires vascular access (VA) through an arteriovenous fistula (AVF), a prosthetic arteriovenous graft (AVG), or a ...

ByHumacyte, Inc.


Arteriovenous Fistulae for Haemodialysis: A Systematic Review and Metaanalysis of Efficacy and Safety Outcomes

Arteriovenous Fistulae for Haemodialysis: A Systematic Review and Metaanalysis of Efficacy and Safety Outcomes

Although AVF had been recommended since 1997, in 2003, the National Kidney Foundation (NKF) set forth the Fistula First Breakthrough Initiative (FFBI), recommending fistula rates of 50% for incident (first placed access), and 40% for prevalent (patient had previous surgically created accesses) patients undergoing HD. The current goal for fistula ...

ByHumacyte, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT